Crexi, a leading marketplace and technology platform that is revolutionizing the commercial real estate (CRE) industry, has successfully raised $111 million in its latest funding round. This significant capital infusion demonstrates the confidence investors have in Crexi鈥檚 vision to streamline CRE transactions through innovative workflow management tools and customizable data analytics. With this funding, Crexi plans to enhance its platform further, offering users even more robust features that simplify the entire CRE process from listing to closing. The company aims to amplify its data analytics capabilities, making it easier for users to extract actionable insights and make informed decisions throughout their transactions. This investment will also fuel the company's aggressive expansion strategy, allowing it to scale its operations, improve user experiences, and extend its market reach. By continuously innovating and integrating technology into the CRE industry, Crexi is poised to transform how brokers, investors, and property owners engage in real estate transactions. As the commercial real estate landscape evolves, Crexi remains committed to providing comprehensive solutions that meet the changing needs of its users. For more information about Crexi and its groundbreaking offerings, visit www.crexi.com.
Crexi Secures $111 Million in Series B Funding for Real Estate Marketplace Expansion
Recently funded 路 $111.0M Series bReal Estate
Get the full Crexi company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
$1.5M Pre-seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  NEW ID | Series b | $705.2K | today |
| 2 |  Arist United States | Series b | $14.1M | today |
| 3 |
